ReviveMed

About:

ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites.

Website: https://www.revivemed.io

Twitter/X: revive_med

Top Investors: Good Growth Capital, MassChallenge, Half Court Ventures, TechU Ventures, WorldQuant Ventures LLC

Description:

ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites. The company's technology is based on a network-based machine learning algorithm for integrative analysis of untargeted metabolomic data with other large-scale molecular information, including data from genes, proteins, drugs and diseases, transforming metabolomic data into actionable insights, enabling development of in-house therapeutics for patients suffering from liver diseases and ailments.

Total Funding Amount:

$1.7M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)revive-med.com

Founders:

Ernest Fraenkel, Leila Pirhaji

Number of Employees:

1-10

Last Funding Date:

2022-07-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai